Results 261 to 270 of about 10,740,223 (348)

Introducing the kollaR package: A user-friendly open-access solution for eye-tracking analysis and visualization. [PDF]

Behav Res Methods
Kleberg JL, Hallman AEZ, Astenvald R, Nordgren A, Falck-Ytter T, van den Berg R.   +5 more
europepmc   +1 more source

Open-Access-Themenheft nicht Open Access

Archivalia, 2009
openaire   +2 more sources

Access is Open

Veterinary Medicine and Science, 2015
openaire   +3 more sources

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Natural Products Repository of Costa Rica (NAPRORE-CR): An Open-Access Database. [PDF]

J Chem Inf Model
Acuña-Jiménez DA, Rodríguez-Zúñiga J, Gutiérrez-Ramírez D, Quesada-Grosso R, Conejo-López V, Arce-Villalobos K, Zamora WJ, Medina-Franco JL.   +7 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Open-access RUSH protocol course improves knowledge and perceived confidence among healthcare learners. [PDF]

BMC Med Educ
Cevik AA, Abu-Zidan FM.
europepmc   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Barriers and Enablers to the Production of Open Access Medical Education Platforms: Scoping Review.

JMIR Med Educ
Ahmed AAE, Biswas A, Bempong-Ahun N, Perić I, O'Flynn EP.   +4 more
europepmc   +1 more source